Citation: Pearson RD (2007) Placental Malaria: Hypertension, VEGF, and Prolactin. PLoS Med 4(3): e141. https://doi.org/10.1371/journal.pmed.0040141
Published: March 27, 2007
Copyright: © 2007 Roy Douglas Pearson. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The author received no specific funding for this article.
Competing interests: The author has declared that no competing interests exist.
The findings by Muehlenbachs et al.  that placental malaria (PM) is associated with hypertension in first-time mothers aged 18–20 years is significant, and not to be explained at this time of writing. The authors also provide data suggesting that the maternal–fetal conflict, during chronic PM and hypertension in first-time mothers, involves the VEGF pathway.
Previously [2–5], I have posited that prolactin might have a role in PM and these new findings might provide further indirect evidence for such a role. It should be remembered that there is an extensive and decades-old literature (see Horrobin's chapter 23 in ) on the role of prolactin in hypertension; and more specifically, the relationship between prolactin and pregnancy-related hypertension [7,8].
Regarding the VEGF pathway, Malaguarnera et al.  have recently shown that prolactin induces VEGF production in human macrophages. It is conceivable that hyperprolactinemia (pituitary and/or placental) could up-regulate placental macrophage production of VEGF.
Space does not permit a discussion of the well known fact of increased pregnancy-related prolactin in first-time mothers, but this has been noted elsewhere  concerning maternal malaria.
Although there has been controversy of late [2,10], regarding my “prolactin hypothesis” in maternal malaria, it is time definitive experiments be conducted to ascertain if prolactin is playing a role in PM, and in other infectious diseases as well.
- 1. Muehlenbachs A, Mutabinwa TK, Edmonds S, Fried M, Duffy PE (2006) Hypertension and maternal–fetal conflict during pregnancy. PLoS Med 3: e446.
- 2. Pearson RD (2004) Malaria in pregnancy: The “cortisol” and “prolactin” hypotheses. Clin Infect Dis 39: 146–147.
- 3. Pearson RD (2003) HIV (AIDS), maternal malaria and prolactin. AIDS 17: 2002–2003.
- 4. Pearson RD (2002) Is prolactin responsible for avian, saurian, and mammalian relapse and periodicity of fever in malarial infections? Can J Zool 80: 1313–1315.
- 5. Pearson RD (2001) Prolactin, pregnancy and anaemia in severe malaria. Trends Parasitol 17: 362.
- 6. Horrobin DF (1973) Prolactin: Physiology and clinical significance. Lancaster: MTP Publishing.
- 7. Marlettini MG, Cassani A, Morselli-Labate AM, Crippa S, Contarini A, et al. (1990) Maternal and fetal prolactin in pregnancy-induced hypertension. Arch Gynecol Obstet 247: 73–81.
- 8. Bellmann O, Praetorius D, Sonntag M, Hansmann M, Fimmers R (1987) Relationship between prolactin in amniotic-fluid during early 2nd trimester and pregnancy-induced hypertension. Clin Exp Hypert B. Hypert Preg 6: 34.
- 9. Malaguarnera L, Imbesi RM, Scuto F, D'Amico F, Licata A, et al. (2004) Prolactin increases HO-1 expression and induces VEGF production in human macrophages. J Cell Biochem 93: 197–206.
- 10. Mavoungou E (2006) Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy. Clin Med Res 4: 33–41.